1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)-

Request For Quotation
1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- Basic information
Product Name:1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)-
Synonyms:1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)-;ZB-R-55
CAS:2416593-55-8
MF:C25H23N5O3
MW:441.48
EINECS:
Product Categories:
Mol File:2416593-55-8.mol
1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- Structure
1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- Chemical Properties
density 1.40±0.1 g/cm3(Predicted)
pka8.76±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- Usage And Synthesis
UsesZB-R-55 is an orally active RIPK1 inhibitor. ZB-R-55 can be used for sepsis study[1].
References[1] Yang X, et al. Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis. Angew Chem Int Ed Engl. 2022;61(5):e202114922. DOI:10.1002/anie.202114922
1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- Preparation Products And Raw materials
Tag:1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)-(2416593-55-8) Related Product Information
1H-1,2,4-Triazole-5-carboxamide, 3-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxopyrido[3,2-b][1,4]oxazepin-3-yl]- GSK2982772 1H-1,2,4-Triazole-5-carboxamide, 3-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-7-(3-hydroxy-3-methyl-1-butyn-1-yl)-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]- RIPK1-IN-16 1H-1,2,4-Triazole-5-carboxamide, N-[(3S)-7-(2-cyclopropylethynyl)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-(phenylmethyl)- NA